The synthesis of tumor necrosis factor (TNF)/cachectin was assessed in primary monocyte-derived macrophage (MDM) cultures after in vitro infection with a macrophage-tropic strain of HIV-1 (HTLV-IIIB.Ls ). Productive and cytopathic infections in MDM cultures were established using a high multiplicity of infection (m.o.i. = 3) under conditions that minimized endotoxin contamination. Culture supernatants were tested for TNF/cachectin activity by L929 cell cytotoxicity assay, and
Introduction
Human immunodeficiency virus (HIV) is established as the etiologic agent of AIDS (1, 2) ; however, the pathogenic link between infection and disease remains largely undefined. With the discovery that cells of the monocyte/macrophage lineage serve as viral targets and viral reservoirs (3) (4) (5) (6) (7) (8) (9) , speculation has arisen that the macrophage may play a role in the pathogenesis of AIDS through the dysregulation of one or several macrophage-derived cytokines, including tumor necrosis factor (TNF)'/cachectin (10) . This hypothesis follows from the ob-1. Abbreviations used in this paper: MDM, monocyte-derived macrophage; m.o.i., multiplicity of infection; PCR, polymerase chain reaction; TNF, tumor necrosis factor. [591] [592] [593] [594] [595] [596] servation that at least two viruses, influenza virus (11) and Sendai virus (12) , induce macrophage TNF/cachectin production after in vitro infection. In addition, the multiple effects of TNF/cachectin (13) , which include lipoprotein lipase suppression (14) , pyrogenic activity (15) , and disturbed brain function (16) could account for several of the pathological features of AIDS, including wasting, fevers, and dementia, respectively. Alternatively, a deficient TNF/cachectin response in AIDS might explain host susceptibility to several opportunistic microorganisms, particularly mycobacteria (17) (18) (19) .
Previous studies have produced a contradictory array of results, including an increased (20) , decreased (21) , or normal (22) TNF/cachectin or lymphotoxin production by peripheral blood mononuclear cells isolated from HIV-infected individuals. Two studies have found elevated levels of serum TNF/ cachectin in symptomatic HIV infection (23, 24) , but an additional report found decreased serum TNF/cachectin levels in HIV-infected individuals compared to uninfected controls (25) . In order to determine if HIV infection of macrophages alone causes a disturbance in macrophage TNF/cachectin regulation, an assessment of the synthesis and release ofthis cytokine during in vitro infection is required. We report here that productive and cytopathic infection of monocyte-derived macrophages with a macrophage-tropic HIV-1 strain does not induce detectable TNF/cachectin protein or mRNA production. In addition, infection fails to alter either the kinetics or dose-response of TNF/cachectin production after LPS stimulation, suggesting that HIV infection and replication does not directly alter macrophage TNF/cachectin regulation.
Methods
Macrophage culture. Macrophages were prepared from blood monocytes isolated by sequential fibronectin and plastic adherence (26, 27 TNF/cachectin bioassay. Culture supernatants were assayed for TNF/cachectin in a cytotoxicity assay using L929 cells pretreated with 0.5 ,ug/ml mitomycin C in 96-well microtiter plates. Recombinant human TNF-alpha (2.51 X 107 U/,gg; Genentech, South San Francisco, CA) was assayed in triplicate dilutions to establish a standard curve. 48 h after incubation, plates were fixed in 5% formaldehyde in saline and stained with crystal violet before quantitation ofcytotoxicity with an automated micro-ELISA reader. Results are expressed as TNF/cachectin U/ml. This cytotoxicity assay has a threshold of detection of between 0.1 and I U/ml of recombinant human TNF-a.
TNF/cachectin mRNA. Macrophage cultures were infected in 48-well plates at a multiplicity ofinfection (m.o.i.) -3 as described above. Total cellular RNA was isolated at various times after infection using a modification of the single-step acid guanidinium thiocyanate-phenolchloroform procedure (29) (RNAzol"; Cinna/Biotecx, Friendswood, TX), followed by chloroform extraction, isopropanol precipitation, and resuspension of total cellular RNA in I mM Tris, pH 7.5. An initial round of reverse transcription (MMLV-Reverse transcriptase; Bethesda Research Laboratories, Gaithersburg, MD) provided cDNA targets for subsequent 40 cycle PCR amplification. Polymerase chain reaction (PCR) amplification (30-32) was performed using primer pairs (Genetic Designs, Inc., Houston, TX) chosen to target TNF/cachectin exons spanning three separate intron regions (sense: 5'-GGGAATTCATGAGCACTGAAAGCATGATC-3'; antisense: 5'-GGAAGCTTTCACAGGGCAATGATCCCAAAGTAGACCTG-CCC-3' beginning at positions 152 and 854, respectively, in the cDNA (27) . The production of p24 antigen and infectious virus indicated that significant viral replication was occurring in HIV-infected wells (Table I) . TNF/cachectin release is not induced by HTLV-IIIBL,8s infection. MDM culture supernatants were tested for the presence of TNF/cachectin before, immediately after, and several days after infection with HIV-1. In an assay with a threshold of detection of 0.1 U/ml of recombinant human TNF, spontaneous TNF/cachectin production was not detected in either infected or uninfected cultures before LPS stimulation (Table   II) . This result was consistent with the demonstration that TNF/cachectin production is an inducible and not a constitutive event in MDM cultures which exclude endotoxin contamination (28) . When the same cultures were stimulated with 100 ng/ml LPS 5 d after infection, comparable TNF/cachectin responses occurred in both infected and uninfected cultures (Table II) (Fig. 2) . In four separate experiments, the minimal LPS dose required to induce detectable TNF/cachectin production varied between 10 and 100 pg/ml. Maximal TNF/cachectin production was seen at 6 h after LPS stimulation, with a return to nearly undetectable levels by 96 h. HTLV-III, L/85 infection failed to alter either the dose-response or the kinetics ofTNF/cachectin production in these LPS-stimulated macrophage cultures.
HTL V-IIBaL/85 infection does not induce macrophage TNF/cachectin mRNA production in unstimulated cultures or alter TNF/cachectin mRNA production in LPS-stimulated cultures. TNF/cachectin-specific mRNA was assayed following HIV infection using reverse transcription and PCR amplification (Fig. 3 A) . In unstimulated cultures, no amplification products were present in either infected or uninfected cultures. After LPS stimulation, both infected and uninfected cultures yielded the predicted 702 b.p. amplification product from TNF/cachectin mRNA. Amplified TNF/cachectin mRNA from serial dilutions of an LPS-stimulated culture demon- strated that the detection threshold in these studies was less than a 10-4 dilution of a culture containing 105 cells, or between 1 and 10 cell-equivalents of TNF/cachectin mRNA from a fully activated macrophage culture (Fig. 3 B) . Restriction endonuclease digestion with Hinc II (Fig. 3 6) yielded the expected restriction fragments of the positive samples from was performed (Fig. 3 D) to confirm the presence of cellular RNA and the efficiency of PCR amplification for all samples.
Discussion
The data presented here demonstrate that HTLV-IIIB.L,85 can establish a productive and cytopathic infection in macrophages without altering TNF/cachectin regulation. Our experimental system used a high multiplicity of infection in order to expose the majority of target cells to HIV. This enabled us to assess TNF/cachectin protein and mRNA production shortly after infection, when viral replication was both synchronous and widespread in the culture system, as well as several days after infection when the cytopathic effects were most prominent. Endotoxin contamination was minimized since it may affect HIV replication (27) and since endotoxin induces TNF/ cachectin production in MDMs even at minute concentrations (28) . No TNF/cachectin was released from unstimulated MDMs, whether or not they were infected with HIV. Similarly, cultured macrophages, whether or not they were infected with HIV, contained no detectable TNF/cachectin mRNA. This determination was made by a PCR amplification technique sensitive enough to detect < 10 cell-equivalents of TNF/cachectin mRNA from a fully activated macrophage culture. LPS concentrations as low as 10-100 pg/ml could elicit TNF/cachectin production in our culture system, and the resulting kinetic and dose-response curves from LPS stimulation were indistinguishable between infected and uninfected cultures.
Contradictory results have been generated by studies that have examined TNF/cachectin production by peripheral blood mononuclear cells from individuals infected with HIV.
A deficient response to PHA/PMA stimulation (21) , an unimpaired tumoricidal response to LPS stimulation (22) , and increased baseline and interferon-y stimulated cytolytic activity and TNF/cachectin secretion (20) (23, 24) , but other studies have found either no measurable serum TNF/cachectin in patients with AIDS-related-complex or AIDS (21, 34) or decreased levels when compared to uninfected controls (25) . An additional confounding factor in the interpretation of these studies is that they do not discriminate between a direct effect of HIV infection or in The possibility exists that the failure of HTLV-IIIB,-L,8s to induce potentially pathogenic TNF/cachectin dysregulation is a strain-specific rather than a general characteristic of HIV or that isolation of MDMs by fibronectin adherence selects against a subset of cells particularly responsible for production of this cytokine by HIV infection. In contrast to most other HIV-1 strains, however, HTLV-IIIB.-L,85 replicates to high titers in MDMs without the addition of exogenous cytokines or growth factors. In addition, it produces cytopathology in vitro that is similar to the multinucleated giant cells observed in patients with AIDS at autopsy. These characteristics make HTLV-IIIBaL,85 a suitable prototypic strain for the in vitro demonstration of any putative TNF/cachectin dysregulation that may accompany in vivo HIV infection. The failure of HTLV-IIIB, L85 to alter the production by macrophages of TNF/cachectin transcripts or protein establishes that the constitutive mechanisms of HIV infection and replication operate independently of macrophage TNF/cachectin regulation. If, in fact, TNF/cachectin plays a role in the pathogenesis of infection by HIV, it may be necessary to consider its elaboration by cells other than macrophages or its induction in macrophages as a result of factors other than direct HIV infection. 
